Moritz B. Bastian
Kirrberger Str. 100, Geb. 50
Homburg, SL 66421, Germany
Homburg, SL 66421, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 09, 2026
FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?
Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Published: March 30, 2026
Automated PROMISE V2 Scoring from PSMA PET/CT Reports Using Large Language Models: A Comparative Evaluation of Prompt Design and Model Performance.
Journal: Current oncology (Toronto, Ont.)
Published: March 27, 2026
Zirconium-89-based PSMA PET/CT with delayed imaging for early detection of biochemical recurrence in prostate cancer patients with PSA ≤ 0.2 ng/mL: A feasibility study.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 24, 2026
AI in cervical spine CT: not a second reader, but a value-generating system intervention.
Journal: European radiology
Published: January 03, 2026
Auger Emitting [161Tb]Tb-PSMA-617 Radioligand Therapy in mCRPC with Peritoneal Carcinomatosis.
Journal: Nuclear medicine and molecular imaging
Published: October 15, 2025
Diagnosis of Extra-Skeletal Ewing Sarcoma in an 11-Year-Old Child with Large Thoracic Mass revealed by [18F]FDG PET/CT.
Journal: Nuclear medicine and molecular imaging
Published: September 30, 2025
Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 12, 2025
Outcome and Safety of Radioligand Therapy With [ 161 Tb]Tb-PSMA-617 After Re-Progression in mCRPC Patients Previously Treated With [ 177 Lu]Lu-PSMA-617.
Journal: Clinical nuclear medicine
Published: August 19, 2025
Correction: Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
Journal: Nuklearmedizin. Nuclear medicine
Published: May 20, 2025
Digitalization of Nuclear Medicine in Germany - Status Quo 2024.
Journal: Nuklearmedizin. Nuclear medicine
Published: April 17, 2025
Last Updated: 09/26/2026